重要提醒:2025.12.15 12:00-12:50期间发布的求助,下载出现了问题,现在已经修复完毕,请重新下载即可。如非文件错误,请不要进行驳回。

The effect of Inc parameter on VMAT radiotherapy plans quality for rectal cancer using Monaco TPS

核医学 医学 放射治疗 剂量学 剂量体积直方图 放射治疗计划 结直肠癌 癌症 放射科 内科学
作者
Peng Zhou,Jia Luo,Xiaona Su,Chuan Chen
出处
期刊:Journal of Applied Clinical Medical Physics [Wiley]
卷期号:25 (9)
标识
DOI:10.1002/acm2.14409
摘要

Abstract Background To investigate the effect of the Increment of gantry angle (Inc) parameter setting of the Monaco Treatment planning system (Monaco TPS) on the dosimetry and quality parameters of the volumetric modulated arc therapy (VMAT) program for rectal cancer. Methods A retrospective analysis was conducted on 50 patients with rectal cancer who underwent intensity modulated radiation therapy using the Monaco TPS system from 2020 to 2021. Under the same optimization function configuration and other parameter settings, the Inc parameters in the VMAT radiotherapy plan were set to 10°, 20°, 30°, and 40°. The dose‐volume histogram (DVH) was used to evaluate the dose distribution of the target area and the radiation dose of the organs at risk (OAR). The differences in the dosimetry of the planning target volume (PTV) and OAR, as well as the gamma pass rate (GPR) were compared. Results In terms of target dose, D98, D min , HI, and conformity index (CI) of Inc10 group was significantly lower than those of Inc20, 30, and 40 groups ( P < 0.05), and D2 of Inc10 group was significantly higher than that of Inc20 group ( P = 0.009). We also found CI of Inc20 and 30 were significantly better than that of Inc40 (both P < 0.05). In terms of OAR dose, the study found that the D mean , D min , V 50% , V 45% , and V 40% for the bladder of the Inc10 group were lower than those of the other groups (all P < 0.05), the D mean for femoral head of the Inc20 group was lower than that of the Inc30 group ( P < 0.05), and Inc20 showed a better protective effect on the femoral head. The MUs tend to decrease as the Inc parameter setting is increased. The monitor unit (MU) in Inc10 group were significantly higher than those in Inc20, Inc30, and Inc40 groups, and the MU of Inc20 group was significantly higher than that of Inc40 group (both P < 0.05). We found that for the 3%/3 mm and 2%/2 mm standards, the GPRs of each plan were > 90%, which met clinical requirements. Conclusions Different settings of Inc parameters have varying degrees of impact on target dose, OAR dose, and machine MU. It is important for doctors to choose different Inc parameters according to different clinical needs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乔乔完成签到,获得积分10
1秒前
moerr完成签到,获得积分10
1秒前
1秒前
Loki发布了新的文献求助10
1秒前
RRRabbit发布了新的文献求助10
1秒前
吃吃吃完成签到,获得积分20
1秒前
南边的海发布了新的文献求助10
1秒前
2秒前
科研通AI6应助鳗鱼雨寒采纳,获得10
2秒前
2秒前
2秒前
发顺丰发布了新的文献求助10
2秒前
3秒前
啊TiP发布了新的文献求助10
3秒前
3秒前
景Q同学完成签到,获得积分10
3秒前
乔乔发布了新的文献求助10
3秒前
酷炫的天问完成签到,获得积分10
3秒前
Ava应助少艾采纳,获得10
3秒前
3秒前
年糕111发布了新的文献求助10
5秒前
Akim应助调皮的易槐采纳,获得10
6秒前
Smithjiang发布了新的文献求助10
6秒前
一口完成签到,获得积分10
6秒前
夹心完成签到,获得积分10
6秒前
烟花应助Lucky采纳,获得10
6秒前
glow完成签到,获得积分10
6秒前
同仁来啦发布了新的文献求助10
6秒前
6秒前
8秒前
8秒前
完美世界应助现代的曼香采纳,获得10
8秒前
8秒前
yy发布了新的文献求助10
8秒前
香蕉若风发布了新的文献求助30
8秒前
WWQ发布了新的文献求助10
9秒前
Ent_关注了科研通微信公众号
10秒前
222完成签到 ,获得积分20
10秒前
无味完成签到 ,获得积分10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1001
On the application of advanced modeling tools to the SLB analysis in NuScale. Part I: TRACE/PARCS, TRACE/PANTHER and ATHLET/DYN3D 500
L-Arginine Encapsulated Mesoporous MCM-41 Nanoparticles: A Study on In Vitro Release as Well as Kinetics 500
Haematolymphoid Tumours (Part A and Part B, WHO Classification of Tumours, 5th Edition, Volume 11) 400
Virus-like particles empower RNAi for effective control of a Coleopteran pest 400
Unraveling the Causalities of Genetic Variations - Recent Advances in Cytogenetics 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5466602
求助须知:如何正确求助?哪些是违规求助? 4570422
关于积分的说明 14325272
捐赠科研通 4496951
什么是DOI,文献DOI怎么找? 2463624
邀请新用户注册赠送积分活动 1452586
关于科研通互助平台的介绍 1427567